Accessibility Menu
Pfizer logo

Pfizer

(NYSE) PFE

Current Price$24.25
Market Cap$138.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1968)+33,070%
5 Year-22%
1 Year+2%
1 Month-7%

Pfizer Financials at a Glance

Market Cap

$138.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$63.32B

Net Income (TTM)

$7.49B

EPS (TTM)

$1.30

P/E Ratio

18.59

Dividend

$1.72

Beta (Volatility)

0.40 (Low)

Price

$24.25

Volume

54,669.327

Open

$24.37

Previous Close

$24.25

Daily Range

$24.14 - $24.43

52-Week Range

$23.11 - $28.75

Estimated Earnings Date

Aug 4, 2026

PFE: Motley Fool Moneyball Superscore

58

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pfizer

Industry

Pharmaceuticals

Employees

75,000

CEO

Albert Bourla, PhD, DVM

Headquarters

New York City, NY 10001-2192, US

PFE Financials

Key Financial Metrics (TTM)

Gross Margin

69.35%

Operating Margin

23.45%

Net Income Margin

11.83%

Return on Equity

8.37%

Return on Capital

10.03%

Return on Assets

3.61%

Earnings Yield

5.38%

Dividend Yield

7.09%

Payout Ratio

1.31%

Stock Overview

Market Cap

$138.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.70B

Volume

54.67K

Avg. Volume

40.49M

Financials (TTM)

Gross Profit

$43.91B

Operating Income

$14.85B

EBITDA

$16.75B

Operating Cash Flow

$11.99B

Capital Expenditure

-$2.50B

Free Cash Flow

$9.48B

Cash & ST Invst.

$13.08B

Total Debt

$64.46B

Pfizer Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$14.45B

+5.4%

Gross Profit

$9.72B

-1.1%

Gross Margin

67.26%

N/A

Market Cap

$138.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.84M

N/A

Employees

75,000

N/A

Net Income

$2.69B

-9.4%

EBITDA

$5.02B

-0.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$13.08B

-24.5%

Total Debt

$64.46B

+5.2%

Accounts Receivable

$12.59B

-14.6%

Inventory

$10.67B

-1.7%

Long Term Debt

$60.57B

+6.6%

Short Term Debt

$3.89B

-13.0%

Return on Assets

3.61%

N/A

Return on Invested Capital

8.57%

N/A

Free Cash Flow

$2.18B

+23.0%

Operating Cash Flow

$2.62B

+12.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
DHRDanaher Corporation
$199.05-0.55%
SYKStryker Corporation
$311.07-6.15%
BMYBristol-Myers Squibb Company
$56.95-4.03%
GILDGilead Sciences, Inc.
$130.04-1.04%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$38.63-0.03%
TQQQProShares Trust - ProShares UltraPro Qqq
$75.02+0.03%
NXTCNextCure
$6.58+2.02%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$14.18+0.06%

Questions About PFE

What is the current price of Pfizer?

Pfizer is trading at $24.25 per share.

What is the 52-week range for Pfizer?

Over the past 52 weeks, Pfizer has traded between $23.11 and $28.75.

How much debt does Pfizer have?

As of the most recent reporting period, Pfizer reported total debt of $64.46B.

How much cash does Pfizer have on hand?

Pfizer reported $1.70B in cash and cash equivalents in its most recent financial results.

What is Pfizer’s dividend yield?

Pfizer currently has a dividend yield of 7.09%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.